Cardioprotective effect of Taurhythman: the experimental study.
Krylova
Irina B
IB
Institute of Experimental Medicine, Russian Academy of Medical Sciences, Saint-Petersburg, Russia 197376. irinakrylova@gmail.com
Evdokimova
Nataliya R
NR
Gavrovskaya
Ludmila K
LK
Sapronov
Nikolay S
NS
D000157:Aconitine / Q000633:toxicity; D017738:Alkanesulfonic Acids / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000378:metabolism / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D002122:Calcium Chloride / Q000633:toxicity; D002316:Cardiotonic Agents / Q000378:metabolism / Q000627:therapeutic use; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar
D017738:Alkanesulfonic Acids; D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; C513229:N-(1-methyl-2-phenylethyl)aminoethane sulfonic acid isopropylamide; D002122:Calcium Chloride; D000157:Aconitine